These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11847528)

  • 1. Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice.
    Queiroz CM; Alcântara FB; Yagüe AM; Bibancos T; Frussa-Filho R
    Braz J Med Biol Res; 2002 Feb; 35(2):237-42. PubMed ID: 11847528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of buspirone on dopaminergic supersensitivity.
    Queiroz CM; Frussa-Filho R
    Life Sci; 1997; 61(4):371-82. PubMed ID: 9244363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of melatonin on behavioral dopaminergic supersensitivity.
    Abílio VC; Vera JA; Ferreira LS; Duarte CR; Martins CR; Torres-Leite D; Ribeiro Rde A; Frussa-Filho R
    Life Sci; 2003 May; 72(26):3003-15. PubMed ID: 12706487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats.
    Frussa-Filho R; Abílio VC; Bergamo M; Palermo-Neto J
    J Pharm Pharmacol; 1997 Apr; 49(4):412-5. PubMed ID: 9232539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monosialoganglioside on dopaminergic supersensitivity.
    Vital MA; Frussa-Filho R; Palermo-Neto J
    Life Sci; 1995; 56(26):2299-307. PubMed ID: 7791517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of continuous exposure to light on behavioral dopaminergic supersensitivity.
    Abílio VC; Freitas FM; Dolnikoff MS; Castrucci AM; Frussa-Filho R
    Biol Psychiatry; 1999 Jun; 45(12):1622-9. PubMed ID: 10376124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats.
    Overstreet DH; Knapp DJ; Breese GR
    Alcohol Clin Exp Res; 2007 Sep; 31(9):1473-81. PubMed ID: 17624999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of single and long-term haloperidol administration on open field behavior of rats.
    Bernardi MM; De Souza H; Palermo Neto J
    Psychopharmacology (Berl); 1981; 73(2):171-5. PubMed ID: 6785810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notes on buspirone's mechanisms of action.
    Garattini S; Caccia S; Mennini T
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.
    Gattaz WF; Emrich A; Behrens S
    J Neural Transm Gen Sect; 1993; 92(2-3):197-201. PubMed ID: 8369109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of GM1 effects on haloperidol-induced dopaminergic supersensitivity.
    Palermo-Neto J; Frussa-Filho R; Vital MA
    Gen Pharmacol; 1999 Feb; 32(2):265-70. PubMed ID: 10188630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.
    Pich EM; Samanin R
    Psychopharmacology (Berl); 1986; 89(1):125-30. PubMed ID: 2874581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diltiazem suppresses quinpirole-induced oral stereotypies in haloperidol withdrawn rats.
    Pucilowski O; Eichelman B
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):717-22. PubMed ID: 1683487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.